Our Story
Our Story
It was truly the worst nightmare. My wife and I were working diligently at our public jobs to help support the planting of an original Christian Church in Tampa FL. In 2017 after hand surgery she immediately noticed something was off the next day. In a short period of time we found out that she had developed a rare and the most painful disease known to man called CRPS.
CRPS, or Chronic Regional Pain Syndrome, is the highest in pain on the McGill scale and is likened to having an amputation without anesthesia, but the pain doesn’t go away. Tragically only 10 to 30% of CRPS sufferers will respond, and typically marginally, to different standard of care treatments. This has left many of CRPS sufferers hopeless and thus we have such a high suicide attempt rate in the CRPS population. It Is estimated that 5 to 14% of CRPS patients attempt suicide at least one time. That translates to about seven people trying to commit suicide every day in the US.
My background includes research in pain drug discovery while at GlaxoSmithKline and a biotech company called Amphora Discovery. In noticing her pain type I immediately began to think of different enzymes, receptors and ion channels which would be involved in her pain processes. Upon researching natural products which impact those particular targets I put together a formulation which worked fairly well for her. It was so remarkable to see her go from curled up in excruciating pain too seeing relief in 30 minutes. It was truly an answer to prayer.
We didn’t really know how well this formulation worked as Lori was receiving a variety of treatments at the same time, which is how they typically attack the CRPS. Recently I was able to connect with other CRPS sufferers who were able to try the formula and the results were remarkable. Then I was able to modify it to improve the results even more. From the results and testimonial pages, you can see that we will not only have the potential to help the CRPS community tremendously but also the chronic pain community and opioid addiction.
The cost of bringing this type of formulation to market is well over $1 million. This covers the cost of manufacturing and all of the requirements for FDA approval.
Our intent is to get this product in the hands of CRPS patients as quickly as possible and then expand to the chronic pain Community as well as those addicted to opioids.
